Career

Harriet Kluger has accepted accepted candidacy for At-Large Director in Society for Immunotherapy of Cancer (SITC) – Yale Cancer Center

Photo taken from: Yale Cancer Center/LinkedIn

May 1, 2024, 19:55

Harriet Kluger has accepted accepted candidacy for At-Large Director in Society for Immunotherapy of Cancer (SITC) – Yale Cancer Center

Yale Cancer Center shared on their LinkedIn page:

“We are pleased to share that Harriet Kluger, MD, Harvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology, has been nominated and accepted candidacy for one of three open At-Large Director positions with the Society for Immunotherapy of Cancer (SITC).

Please take a moment to review Dr. Kluger’s biography and platform statement.
and join Yale Cancer Center in supporting Dr. Kluger!

Voting opens for SITC members on Thursday, May 2.”

Source: Yale Cancer Center/LinkedIn
OncoDaily

cancer Cancer research cancer treatment 𝐃𝐞𝐫𝐦𝐚𝐭𝐨𝐥𝐨𝐠𝐲 Harriet Kluger Healthcare Leadership healthcare professionals immunotherapy medical advocacy Medical Announcement Medical Biography medical community Medical Director Medical Leadership Medical Nomination Medical Platform Medical Support Medical Voting OncoDaily Oncology SITC Society for Immunotherapy of Cancer Yale Cancer Center

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage